Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.

George CholankerilRobert J WongMenghan HuRyan B PerumpailEric R YooPuneet PuriZobair M YounossiStephen A HarrisonAndrew A Li

Published in: Digestive diseases and sciences (2017)

Currently, NASH is the most rapidly growing indication for LT in the US. Despite resurgence in ALD, NASH remains the second leading indication for LT.

Keyphrases

type diabetes
metabolic syndrome
skeletal muscle
weight loss